Stay updated on Entinostat Plus Pembrolizumab in Advanced Cancers Clinical Trial
Sign up to get notified when there's something new on the Entinostat Plus Pembrolizumab in Advanced Cancers Clinical Trial page.

Latest updates to the Entinostat Plus Pembrolizumab in Advanced Cancers Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe page revision was updated from v3.6.2 to v3.6.3, indicating a new version of the page likely containing minor updates or fixes rather than substantive content changes.SummaryDifference0.0%

- Check16 days agoChange Detected- The page revision was updated from v3.6.0 to v3.6.2, indicating a newer patch level. - The update appears to be a minor maintenance change with no substantive content changes.SummaryDifference0.0%

- Check30 days agoChange DetectedThe update adds new navigation/help sections such as 'How to Read a Study Record', 'Common Questions', and 'How to Join a Study', and adjusts the 'Intervention/Treatment' header formatting, along with a new page revision label (v3.6.0); it also includes a recruitment status change indicating no further enrollment.SummaryDifference0.3%

- Check37 days agoChange DetectedThe page now shows Revision: v3.5.5, replacing the previous Revision: v3.5.4. This appears to be a metadata/version update and does not modify the study content or visible data.SummaryDifference0.0%

- Check59 days agoChange DetectedThe study documentation now shows revision v3.5.4, replacing the prior v3.5.3. This indicates an administrative update to the study materials on the page.SummaryDifference0.0%

- Check80 days agoChange DetectedThe page revision/version indicator was updated from v3.5.2 to v3.5.3, reflecting an interface or release version change rather than any new study details.SummaryDifference0.0%

Stay in the know with updates to Entinostat Plus Pembrolizumab in Advanced Cancers Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Entinostat Plus Pembrolizumab in Advanced Cancers Clinical Trial page.